Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Barwick

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|March 8, 2020
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myelomaRicha Bajpai, Aditi Sharma, Abhinav Achreja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2021
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple MyelomaBenjamin G Barwick, Vikas A Gupta, Shannon M Matulis, et al.
Cell Reports|June 25, 2020
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell SurvivalAdam Utley, Colin Chavel, Shivana Lightman, et al.
Blood|March 2, 2021
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expressionVikas A Gupta, Benjamin G Barwick, Shannon M Matulis, et al.
Science Advances|September 28, 2022
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myelomaAditi Sharma, Remya Nair, Abhinav Achreja, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
KDM6A Regulates Immune Response Genes in Multiple MyelomaDaphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.
Molecular Therapy Oncolytics|March 19, 2021
Oncolytic herpes simplex virus infects myeloma cells <i>in vitro</i> and <i>in vivo</i>Jayeeta Ghose, Ada Dona, Mariam Murtadha, et al.
Blood|July 24, 2024
KDM6A regulates immune response genes in multiple myelomaDaphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, et al.
Blood Cancer Discovery|November 15, 2021
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom MacroglobulinemiaAkhilesh Kaushal, Ajay K Nooka, Allison R Carr, et al.
Blood Cancer Journal|August 4, 2022
Venetoclax ex vivo functional profiling predicts improved progression-free survivalVikas A Gupta, Shannon M Matulis, Benjamin G Barwick, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|March 8, 2020
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myelomaRicha Bajpai, Aditi Sharma, Abhinav Achreja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2021
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple MyelomaBenjamin G Barwick, Vikas A Gupta, Shannon M Matulis, et al.
Cell Reports|June 25, 2020
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell SurvivalAdam Utley, Colin Chavel, Shivana Lightman, et al.
Blood|March 2, 2021
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expressionVikas A Gupta, Benjamin G Barwick, Shannon M Matulis, et al.
Science Advances|September 28, 2022
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myelomaAditi Sharma, Remya Nair, Abhinav Achreja, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
KDM6A Regulates Immune Response Genes in Multiple MyelomaDaphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.
Molecular Therapy Oncolytics|March 19, 2021
Oncolytic herpes simplex virus infects myeloma cells <i>in vitro</i> and <i>in vivo</i>Jayeeta Ghose, Ada Dona, Mariam Murtadha, et al.
Blood|July 24, 2024
KDM6A regulates immune response genes in multiple myelomaDaphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, et al.
Blood Cancer Discovery|November 15, 2021
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom MacroglobulinemiaAkhilesh Kaushal, Ajay K Nooka, Allison R Carr, et al.
Blood Cancer Journal|August 4, 2022
Venetoclax ex vivo functional profiling predicts improved progression-free survivalVikas A Gupta, Shannon M Matulis, Benjamin G Barwick, et al.
Pageof 7